anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
BioNTech · conference-presentation

BioNTech | Results Presentation Deck | 43 slides

43 pages · 5 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

BioNTech | Results Presentation Deck | 43 slides

BioNTech · 2021-08
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 30 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 4 slides 100% 4/4 slides 100% 4/4 slides · 21 hits
— 0/4 slides
25% 1/4 slides 25% 1/4 slides 100% 4/4 slides 75% 3/4 slides Solution 11 slides 100% 11/11 slides 100% 11/11 slides · 55 hits
— 0/11 slides
63.6% 7/11 slides · 10 hits 27.3% 3/11 slides 100% 11/11 slides · 19 hits 100% 11/11 slides · 17 hits Market Size 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits
— 0/2 slides
100% 2/2 slides
— 0/2 slides
100% 2/2 slides · 4 hits 100% 2/2 slides Product 11 slides 100% 11/11 slides 100% 11/11 slides · 60 hits
— 0/11 slides
81.8% 9/11 slides · 12 hits 45.5% 5/11 slides 100% 11/11 slides · 17 hits 100% 11/11 slides · 17 hits Team 2 slides 100% 2/2 slides 100% 2/2 slides · 7 hits
— 0/2 slides
100% 2/2 slides
— 0/2 slides
100% 2/2 slides 100% 2/2 slides

Slide inventory

43
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
This is a standard pharmaceutical regulatory disclosure slide.other
Open slide detail
04
Includes specific adverse reaction percentages for different age groups and reporting instructions.other
Open slide detail
05
front_matter
Open slide detail
06
front_matter
Open slide detailBeat · Problem
07
The slide uses a process-flow style diagram to connect internal capabilities to pipeline output and future market launches.summarize
Open slide detailBeat · ProblemLoop · Golden Circle
08
The slide uses a structured layout to categorize achievements into three main pillars: COVID-19 vaccine, pipeline expansion, and corporate updates.summarize
Open slide detailBeat · ProblemLoop · Golden Circle
09
Slide 9 of a BioNTech presentation.summarize
Open slide detailBeat · ProblemLoop · Golden Circle
10
The slide uses a central hub-and-spoke diagram to connect technology platforms (mRNA, T-cell, Antibodies, Small Molecules, Ribologicals) to therapeutic applicatpresent_framework
Open slide detailBeat · SolutionLoop · Golden Circle
11
present_solution
Open slide detailBeat · SolutionLoop · Golden Circle
12
transition
Open slide detailBeat · SolutionLoop · Golden Circle
13
The slide highlights BioNTech's global reach and commitment to equitable access.analyze_data
Open slide detailBeat · SolutionLoop · Golden Circle
14
summarize
Open slide detailBeat · SolutionLoop · Golden Circle
15
Includes clinical trial data for BNT162b2 vs placebo.summarize
Open slide detailBeat · SolutionLoop · Golden Circle
16
Includes a dot plot for antibody titers, a sequence alignment table for T-cell epitopes, and a summary table for real-world effectiveness.analyze_data
Open slide detailBeat · SolutionLoop · Golden Circle
17
The slide uses a numbered process flow combined with a data table to show clinical trial progression.plan_implementation
Open slide detailBeat · SolutionLoop · Golden Circle
18
Includes two sets of bar charts comparing neutralizing titers across age groups and vaccine doses.analyze_data
Open slide detailBeat · SolutionLoop · Golden Circle
19
front_matter
Open slide detailBeat · SolutionLoop · Golden Circle
20
The slide uses a hub-and-spoke style diagram to illustrate how different therapeutic modalities (mRNA, CAR-T, Antibodies, Small Molecules, Engineered Biologicalpresent_solution
Open slide detailBeat · SolutionLoop · Golden Circle
21
The slide uses a timeline-like visual representation for clinical phases.plan_implementation
Open slide detailBeat · ProductLoop · Golden Circle
22
The slide uses a combination of a conceptual process diagram and flow cytometry data plots to validate the mechanism of action.present_solution
Open slide detailBeat · ProductLoop · Golden Circle
23
The slide uses a combination of quantitative metrics and qualitative clinical context to establish the problem.diagnose_problem
Open slide detailBeat · ProductLoop · Golden Circle
24
Includes a citation to a Nature publication and a visual representation of the mRNA construct.summarize
Open slide detailBeat · ProductLoop · Golden Circle
25
Clinical trial design diagram showing randomization of 120 patients into three arms.present_framework
Open slide detailBeat · ProductLoop · Golden Circle
26
The slide uses a geographic map to illustrate disease prevalence and a table to highlight low ORR and mOS for existing therapies.diagnose_problem
Open slide detailLoop · Golden Circle
27
The slide uses a diagram to illustrate the mRNA structure of BNT113 encoding HPV-E6 and HPV-E7.present_solution
Open slide detailLoop · Golden Circle
28
Includes patient-level response table, pie chart of response types, and visual ELISPOT assay results for patients 6 and 7.analyze_data
Open slide detailLoop · Golden Circle
29
Clinical trial design diagram showing Part A (safety run-in) and Part B (randomization).present_framework
Open slide detailLoop · Golden Circle
30
The diagram uses a process flow structure to show patient progression from surgery through screening to treatment allocation.present_framework
Open slide detailLoop · Golden Circle
31
Includes a visual comparison of PK profiles (recombinant vs RiboCytokine) and a pipeline table for BNT151 and BNT152+153.present_solution
Open slide detailLoop · Golden Circle
32
Slide 32 of a presentation, likely BioNTech R&D day.present_solution
Open slide detailLoop · Golden Circle
33
The slide uses a three-column layout to categorize trial updates, phase 2 starts, and phase 1 starts.summarize
Open slide detailLoop · Golden Circle
34
transition
Open slide detailLoop · Golden Circle
35
The table shows a significant increase in commercial revenues and operating profit compared to the prior year.analyze_data
Open slide detailBeat · TeamLoop · Golden Circle
36
The chart uses a stacked bar format to decompose revenue into four categories, with a specific focus on COVID-19 vaccine revenue.analyze_data
Open slide detailBeat · TeamLoop · Golden Circle
37
The slide uses a structured layout with three distinct sections for revenue, expenses, and tax.analyze_data
Open slide detailLoop · Golden Circle
38
front_matter
Open slide detailLoop · Golden Circle
39
The slide uses a hub-and-spoke diagram to categorize therapeutic modalities. Bottom text highlights a specific recent transaction (Kite).present_solution
Open slide detailLoop · Golden Circle
40
summarize
Open slide detailLoop · Golden Circle
41
Slide 41 from a BioNTech presentation.present_solution
Open slide detailLoop · Golden Circle
42
summarize
Open slide detailLoop · Golden Circle
43
other
Open slide detail